JP4685242B2 - ヒアルロン酸を用いた放射線膀胱炎の予防、軽減、および治療法 - Google Patents

ヒアルロン酸を用いた放射線膀胱炎の予防、軽減、および治療法 Download PDF

Info

Publication number
JP4685242B2
JP4685242B2 JP2000577997A JP2000577997A JP4685242B2 JP 4685242 B2 JP4685242 B2 JP 4685242B2 JP 2000577997 A JP2000577997 A JP 2000577997A JP 2000577997 A JP2000577997 A JP 2000577997A JP 4685242 B2 JP4685242 B2 JP 4685242B2
Authority
JP
Japan
Prior art keywords
radiation therapy
bladder
hyaluronic acid
radiation
week
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2000577997A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002528410A (ja
JP2002528410A5 (enExample
Inventor
ジェイ． ポンマービル，ピーター
Original Assignee
バイオニケ・テオランタ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオニケ・テオランタ filed Critical バイオニケ・テオランタ
Publication of JP2002528410A publication Critical patent/JP2002528410A/ja
Publication of JP2002528410A5 publication Critical patent/JP2002528410A5/ja
Application granted granted Critical
Publication of JP4685242B2 publication Critical patent/JP4685242B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2000577997A 1998-10-22 1999-10-22 ヒアルロン酸を用いた放射線膀胱炎の予防、軽減、および治療法 Expired - Lifetime JP4685242B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10518498P 1998-10-22 1998-10-22
US60/105,184 1998-10-22
PCT/CA1999/000994 WO2000024387A2 (en) 1998-10-22 1999-10-22 A method for preventing, reducing, and treating radiation cystitis using hyaluronic acid

Publications (3)

Publication Number Publication Date
JP2002528410A JP2002528410A (ja) 2002-09-03
JP2002528410A5 JP2002528410A5 (enExample) 2007-08-30
JP4685242B2 true JP4685242B2 (ja) 2011-05-18

Family

ID=22304511

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000577997A Expired - Lifetime JP4685242B2 (ja) 1998-10-22 1999-10-22 ヒアルロン酸を用いた放射線膀胱炎の予防、軽減、および治療法

Country Status (12)

Country Link
US (2) US6667296B1 (enExample)
EP (1) EP1124546B1 (enExample)
JP (1) JP4685242B2 (enExample)
AT (1) ATE264674T1 (enExample)
AU (1) AU761158B2 (enExample)
CA (1) CA2347110C (enExample)
DE (1) DE69916643T2 (enExample)
DK (1) DK1124546T3 (enExample)
ES (1) ES2219070T3 (enExample)
NZ (1) NZ511068A (enExample)
PT (1) PT1124546E (enExample)
WO (1) WO2000024387A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9906619D0 (en) † 1999-03-23 1999-05-19 Zeneca Resins Bv Compositions
US20070173479A1 (en) * 2003-12-10 2007-07-26 Keryx Biopharmaceuticals, Inc. Methods Using Sulodexide for the Treatment of Bladder Disease
JP2007233949A (ja) * 2006-03-03 2007-09-13 Kyoto Univ 排尿管理システム
ITMI20061030A1 (it) 2006-05-26 2007-11-27 Altergon Sa Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
DE102006060953A1 (de) 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
HUP0900717A3 (en) * 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
EP3960215B1 (en) 2009-12-15 2024-10-16 Incept, LLC Implants and biodegradable fiducial markers
RU2557949C1 (ru) * 2014-08-14 2015-07-27 Общество с ограниченной ответственностью "КОЛЕТЕКС" Способ лечения лучевого и интерстициального цистита
WO2016146573A1 (en) * 2015-03-13 2016-09-22 Repoceuticals Aps Melatonin for preventing and treating radiation cystitis
RU2676431C1 (ru) * 2018-02-26 2018-12-28 Федеральное государственное бюджетное учреждение "Российский научный центр радиологии и хирургических технологий имени академика А.М. Гранова" Министерства здравоохранения Российской Федерации (ФГБУ "РНЦРХТ им. ак. А.М. Гранова" Минздрава России) Способ моделирования лучевого цистита
WO2019236453A1 (en) * 2018-06-03 2019-12-12 Glycomira Therapeutics, Inc. Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and /or chemotherapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN181358B (enExample) * 1995-02-14 1998-05-30 Bioniche Inc
US5880108A (en) * 1995-02-14 1999-03-09 Bioniche, Inc. Method for treating the internal urinary bladder and associated structures using hyaluronic acid
CA2154103C (en) 1995-07-18 1998-02-24 Samuel Simon Asculai Treatment of mucous membrane disease, trauma or condition and for the relief of pain
WO1998029125A1 (fr) * 1996-12-27 1998-07-09 Seikagaku Corporation Remedes contre des troubles de la vessie

Also Published As

Publication number Publication date
CA2347110C (en) 2008-08-26
JP2002528410A (ja) 2002-09-03
EP1124546A2 (en) 2001-08-22
DE69916643D1 (de) 2004-05-27
AU6455899A (en) 2000-05-15
NZ511068A (en) 2003-10-31
WO2000024387A3 (en) 2000-08-03
US20040152662A1 (en) 2004-08-05
WO2000024387A2 (en) 2000-05-04
PT1124546E (pt) 2004-08-31
ATE264674T1 (de) 2004-05-15
EP1124546B1 (en) 2004-04-21
DE69916643T2 (de) 2005-04-28
CA2347110A1 (en) 2000-05-04
US6667296B1 (en) 2003-12-23
DK1124546T3 (da) 2004-08-09
AU761158B2 (en) 2003-05-29
ES2219070T3 (es) 2004-11-16

Similar Documents

Publication Publication Date Title
JP4354528B2 (ja) 間質性膀胱炎の治療へのヒアルロン酸の使用
Roussos et al. Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections
JP3256761B2 (ja) 症状及び疾病の治療
RU2162327C2 (ru) Лечение рака и профилактика метастазирования
Woodley et al. The treatment of severe staphylococcal infections with vancomycin
US8906883B2 (en) Treatment of oral mucositis by administering an ionic complex of chitosan and a negatively charged polysaccharide selected from heparin, heparan sulfate and dextran sulfate
JP4685242B2 (ja) ヒアルロン酸を用いた放射線膀胱炎の予防、軽減、および治療法
US5880108A (en) Method for treating the internal urinary bladder and associated structures using hyaluronic acid
US6232301B1 (en) Remedies for bladder disorders
KR20200004833A (ko) 방광염을 치료하기 위해 저장 안정성이 증가된, 콘드로이틴 설페이트 (20 mg/ml), 히알루론산 (16 mg/ml) 및 포스페이트 버퍼 (ph 6.1 내지 7.9)를 함유하며 방광 점적 주입 조성물
Aguado et al. Salmonella infections of the abdominal aorta cured with prolonged antibiotic treatment
Koshariya et al. Role of topical Sucralfate in healing of burn wounds
Fair et al. Renal abscess
CA2779937C (en) Pharmaceutical composition for the treatment of bladder disorders
US6548487B2 (en) Agent for treatment of bladder troubles
RU2702607C1 (ru) Способ лечения туберкулеза мочевого пузыря
Al-Khuwaitir et al. Chronic granulomatous disease with recurrent hepatic abscesses in an adult
RU2297837C2 (ru) Способ регионарного лечения флегмон челюстно-лицевой области
US20140220094A1 (en) Methods and compositions for a laparoscopic surgery
RU2342143C2 (ru) Способ комплексной терапии больных острым гнойным пиелонефритом
King Remarks on Sepsis and Its Treatment
CZ288292B6 (en) Compound therapeutic preparations intended for treatment of diseases or states of tissues comprising insufficiently perfused tissues and pathological tissues of human being

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20060831

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20060831

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20060904

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20060921

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061020

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070710

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20070822

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20070823

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20070822

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20070823

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100514

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100721

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100728

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101115

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110111

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110210

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140218

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4685242

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term